RxDoctor Payments Data

Rosemarie Paolini, NP

Psychiatric/Mental Health, Adult · Brockton, MANPI 1225025877

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 28.1% of the total. Among psychiatric/mental health, adult clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,550in general payments, 2019–2025

Across 242 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$678
  • Alkermes, Inc.$431
  • Axsome Therapeutics, Inc.$382
  • Sunovion Pharmaceuticals Inc.$247
  • plus $531 from 7 others

What the payments were for

  • Food & beverage$4,47298%
  • Education$782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,550 in reported general payments places this provider in the 95th percentile of 92 psychiatric/mental health, adult providers in Massachusetts.

See all psychiatric/mental health, adult providers in Massachusetts

Medicare billing

Part B allowed, 2024
$136,201
Medicare patients
484
Services billed
1,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide12$13,009
Lamotrigine ErLamotrigine15$3,632
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$1,672
Doxepin Hcl34$1,388
Bupropion XlBupropion Hcl40$993
Quetiapine Fumarate71$982
Gabapentin66$951
Lamotrigine50$845
Escitalopram Oxalate60$810
Buspirone Hcl50$773
Methylphenidate Hcl25$745
Venlafaxine Hcl ErVenlafaxine Hcl35$679
Trazodone Hcl43$545
Memantine Hcl15$545
Mirtazapine27$544

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health, adult in Brockton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →